Compass Therapeutics CMPX
NASDAQ CMPX
$0.82 -0.02 (-1.94%)
As of: Oct 21, 2026 · 1:22 PM EDT

Compass Therapeutics (CMPX) Other Operating Expenses (2021)

Updated

Compass Therapeutics (CMPX) reported Other Operating Expenses of $50.62 million for FY2021.

Analysis

Compass Therapeutics (CMPX) Other Operating Expenses (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,209.53 Bn 1,178.12 Bn 19.71 Bn
2 Johnson & Johnson 625.18 Bn 543.70 Bn 17.26 Bn
3 AbbVie 510.63 Bn 483.79 Bn 12.70 Bn
4 Merck 365.88 Bn 320.31 Bn 12.21 Bn
5 Novartis Ag 293.11 Bn 257.51 Bn 11.24 Bn
6 Astrazeneca 261.69 Bn 235.45 Bn 12.86 Bn
7 Amgen 237.29 Bn 192.69 Bn 7.24 Bn
8 Gilead Sciences 194.23 Bn 168.34 Bn 6.22 Bn
9 Pfizer 171.73 Bn 118.68 Bn 10.94 Bn
10 Compass Therapeutics 149.47 Mn -656.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 50.62 Mn
API Access

Compass Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CMPX&period=max&api_key=YOUR_API_KEY